Learn how new research and clinical trials at Memorial Sloan Kettering Cancer Center (MSK) have helped 32-year-old Giancarlo ...

MSK is proud to announce that four Sloan Kettering Institute (SKI) researchers have been named 2025 Marie-Josée Kravis Women ...

A phase 3 trial for myelofibrosis found that adding pelebresib to ruxolitinib was more effective than ruxolitinib alone and ...

Research at MSK Our research impact Research topics Core facilities & resources ...

MSK researchers shed new light on G-quadruplexes, a type of secondary DNA structure that has attracted attention as a ...

Research at MSK Our research impact Research topics Core facilities & resources ...

Research at MSK Our research impact Research topics Core facilities & resources ...

Research at MSK Our research impact Research topics Core facilities & resources ...

Research at MSK Our research impact Research topics Core facilities & resources ...

Research at MSK Our research impact Research topics Core facilities & resources ...

Cancer biologist Scott Lowe uses genetically engineered mouse models to study how the genetic alterations in cancer cells contribute to tumorigenesis, alter treatment response, and create molecular ...

Research at MSK Our research impact Research topics Core facilities & resources ...